Adicet Bio Inc (ACET)
NASDAQ:ACET
Want to see ACET full AI Analyst Report?
Total Valuation
Adicet Bio has a market cap or net worth of $77.59M. The enterprise value is $55.24M.
Market Cap$77.59M
Enterprise Value$55.24M
Share Statistics
Adicet Bio has 9,348,236 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,348,236
Owned by Insiders22.02%
Owned by Institutions44.52%
Financial Efficiency
Adicet Bio’s return on equity (ROE) is -0.73 and return on invested capital (ROIC) is -70.18%.
Return on Equity (ROE)-0.73
Return on Assets (ROA)-0.61
Return on Invested Capital (ROIC)-70.18%
Return on Capital Employed (ROCE)-0.71
Revenue Per Employee0.00
Profits Per Employee-768.44K
Employee Count152
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Adicet Bio is ―. Adicet Bio’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.00
PB Ratio0.36
Price to Fair Value0.36
Price to FCF-0.60
Price to Operating Cash Flow-0.98
PEG Ratio0.02
Income Statement
In the last 12 months, Adicet Bio had revenue of 0.00 and earned -116.80M in profits. Earnings per share was -16.95.
Revenue0.00
Gross Profit-6.38M
Operating Income-122.11M
Pretax Income-116.80M
Net Income-116.80M
EBITDA-115.73M
Earnings Per Share (EPS)-16.95
Cash Flow
In the last 12 months, operating cash flow was -91.34M and capital expenditures -283.00K, giving a free cash flow of -91.62M billion.
Operating Cash Flow-91.34M
Free Cash Flow-91.62M
Free Cash Flow per Share-9.80
Dividends & Yields
Adicet Bio pays an annual dividend of $0.01, resulting in a dividend yield of ―
Dividend Per Share$0.01
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.66
52-Week Price Change-25.61%
50-Day Moving Average7.52
200-Day Moving Average9.51
Relative Strength Index (RSI)56.22
Average Volume (3m)126.67K
Important Dates
Adicet Bio upcoming earnings date is Aug 6, 2026, After Close (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Adicet Bio as a current ratio of 7.47, with Debt / Equity ratio of 9.92%
Current Ratio7.47
Quick Ratio7.47
Debt to Market Cap0.00
Net Debt to EBITDA0.21
Interest Coverage Ratio-3.39K
Taxes
In the past 12 months, Adicet Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Adicet Bio EV to EBITDA ratio is -0.29, with an EV/FCF ratio of -0.35.
EV to Sales0.00
EV to EBITDA-0.29
EV to Free Cash Flow-0.35
EV to Operating Cash Flow-0.36
Balance Sheet
Adicet Bio has $137.59M in cash and marketable securities with $13.90M in debt, giving a net cash position of $123.69M billion.
Cash & Marketable Securities$137.59M
Total Debt$13.90M
Net Cash$123.69M
Net Cash Per Share$13.23
Tangible Book Value Per Share$23.10
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Adicet Bio is $34.83, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$34.83
Price Target Upside323.76% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast―
EPS Growth Forecast27.27%